EUVIMED · CrossrefJournal
Cancer Imaging
ISSN 1470-7330 · Springer Science and Business Media LLC
Latest articles
Pretreatment CT-derived body composition adds prognostic value beyond clinical-inflammatory factors in esophageal squamous cell carcinoma: a two-center retrospective development and external validation study
Diffusion kurtosis imaging-assisted MRI for assessing pathological safe-distance status and fertility-sparing feasibility in FIGO stage IB cervical cancer: a prospective single-center study
Interpretable PET/CT habitat radiomics integrates novel metabolic metrics for postoperative risk stratification in stage I lung adenocarcinoma
An explainable AI system for preoperative prediction of renal sinus fat invasion in clear cell renal cell carcinoma: a multicenter study
Multi-parametric MRI apparent diffusion coefficient and active surveillance in prostate cancer: is it time to re-evaluate the active surveillance inclusion criteria?
A multicenter clinicopathologic and MRI-based multimodal fusion model for predicting axillary lymph node metastasis in breast cancer
An MRI-based clinical decision tool to identify patients benefiting from PSMA PET/MRI in intermediate/high-risk prostate cancer
Differentiation of confluent hepatic fibrosis and mass forming intrahepatic cholangiocarcinoma with infltrative tumor margin (mICCITM) on MR imaging
A novel contrast-enhanced CT classification system for differentiating signet ring cell carcinoma in gastric cancer ovarian metastases: a pathologically correlated study
Interleukin-19 as a novel target for predicting survival in glioblastoma patients using a radiogenomics approach
Comparative evaluation of thyroid nodule ultrasound segmentation models
Dynamic layer_view_scale fusion for multimodal medical segmentation
Biparametric MRI–based whole-gland habitat analysis for pretreatment identification of pathologically high-risk prostate cancer: a two-center study with external validation
Clinical applications of photon-counting CT in abdominal oncologic imaging: a primer for developing a clinical practice
Clinical value of 18F-FDG PET/CT for detecting residual metastatic lymph nodes of DTC before initial radioiodine therapy
New heuristic method for cancer classification using gene expression data
Spatial topology on baseline PET/CT improves risk stratification in disseminated diffuse large B-cell lymphoma: a multicenter study
Predicting ki-67 expression in breast cancer via transformer and multiple instance learning on DCE-MRI
Spectral-habitat analysis and perfusion fingerprinting on contrast-enhanced ultrasound for characterizing tumor perfusion in breast lesions
Longitudinal MRI-based Delta-Habitat model for predicting pathological complete response to neoadjuvant chemoimmunotherapy in head and neck squamous cell carcinoma
Clinical-MRI-IVIM combined model for differentiating thymic epithelial tumors from anterior mediastinal lymphoma in large masses
CT-guided biopsy of pulmonary ground-glass nodules: core-needle biopsy versus fine-needle aspiration
Correction: [18F]FDG PET/CT performs better than CT in determining the bone biopsy site : randomized controlled clinical trial
Recursive partitioning analysis model based on 18F-FDG PET/CT metabolic parameters for recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 inhibitors and chemotherapy
CEUS with VEGFR2-targeted microbubbles for monitoring of early immunotherapy effects in a colorectal cancer model
Multimodal PET–MR segmentation for glioblastoma: complementarity for treatment planning and recurrence definition
Patient understanding of AI-simplified oncology imaging reports requires further validation
Development and multicohort external validation of a preoperative [18F]PSMA-1007 PET-derived deep learning score and multimodal model for predicting biochemical recurrence-free survival after radical prostatectomy
When PSMA is not enough: the diagnostic blind spots of PSMA PET/CT and the added value of [¹⁸F]FDG in high-risk prostate cancer: dual-tracer cohort study
Predictive imaging biomarkers on whole-body diffusion-weighted MRI (WB-DWMRI) and [68Ga]GaPSMA-PET/CT for [177Lu]LuPSMA therapy in metastatic prostate cancer (mCRPC)
EUVIMED